- Home
- SHFS vs AEON Comparison
SHFS vs AEON Comparison
Compare SHFS & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHFS
- AEON
- Stock Information
- Founded
- SHFS 2015
- AEON N/A
- Country
- SHFS United States
- AEON United States
- Employees
- SHFS N/A
- AEON N/A
- Industry
- SHFS Finance: Consumer Services
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- SHFS Finance
- AEON Health Care
- Exchange
- SHFS Nasdaq
- AEON Nasdaq
- Market Cap
- SHFS 24.2M
- AEON 21.6M
- IPO Year
- SHFS N/A
- AEON N/A
- Fundamental
- Price
- SHFS $0.38
- AEON $0.12
- Analyst Decision
- SHFS
- AEON Strong Buy
- Analyst Count
- SHFS 0
- AEON 1
- Target Price
- SHFS N/A
- AEON $5.00
- AVG Volume (30 Days)
- SHFS 321.0K
- AEON 46.5M
- Earning Date
- SHFS 11-12-2024
- AEON 11-13-2024
- Dividend Yield
- SHFS N/A
- AEON N/A
- EPS Growth
- SHFS N/A
- AEON N/A
- EPS
- SHFS 0.10
- AEON 0.34
- Revenue
- SHFS $15,658,629.00
- AEON N/A
- Revenue This Year
- SHFS N/A
- AEON N/A
- Revenue Next Year
- SHFS N/A
- AEON N/A
- P/E Ratio
- SHFS $3.83
- AEON $0.35
- Revenue Growth
- SHFS 7.78
- AEON N/A
- 52 Week Low
- SHFS $0.30
- AEON $0.10
- 52 Week High
- SHFS $1.18
- AEON $17.17
- Technical
- Relative Strength Index (RSI)
- SHFS 45.78
- AEON 26.21
- Support Level
- SHFS $0.36
- AEON $0.10
- Resistance Level
- SHFS $0.42
- AEON $0.22
- Average True Range (ATR)
- SHFS 0.04
- AEON 0.04
- MACD
- SHFS -0.00
- AEON -0.01
- Stochastic Oscillator
- SHFS 40.94
- AEON 4.83
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.